OR WAIT null SECS
“Lab to Life” partnership aims to better analyze clinical, real-world and commercial data
Syneos Health, a biopharma clinical and commercial solutions organization, has bolstered its professional relationship with Komodo Health, a data-driven healthcare software company. The partnership will allow Syneos to continue to analyze clinical, real-world and commercial data, offering customers an addition to their operational trial designs and commercialization deployment strategies to further evolve biopharma "Lab to Life" product development.
The newly expanded partnership builds on two years of prior collaboration between the two companies, starting with strategies to improve customer engagement for the Syneos Health Kinetic team.
Powered by Komodo’s Healthcare Map, the new solution integrates Komodo Health’s Prism and Sentinel applications to help support Syneos in conducting studies, analyzing comprehensive and de-identified, aggregated patient data. The result: insight that provides clinical trial design and delivery, and produces real-world evidence on product effectiveness, safety and use in the healthcare system.
This marks Syneos’ second partnership in the last month, having recently teamed up with Medable to bring clinical trials closer to the patient.